Bubley GJ - Search Results

1

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors.

Chen EJ, Sowalsky AG, Gao S, Cai C, Voznesensky O, Schaefer R, Loda M, True LD, Ye H, Troncoso P, Lis RL, Kantoff PW, Montgomery RB, Nelson PS, Bubley GJ, Balk SP, Taplin ME. Chen EJ, et al. Among authors: bubley gj. Clin Cancer Res. 2015 Mar 15;21(6):1273-80. doi: 10.1158/1078-0432.CCR-14-1220. Epub 2014 Oct 15. Clin Cancer Res. 2015. PMID: 25320358 Free PMC article.

2

Detection of circulating tumor cells in men with localized prostate cancer.

Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Seiden MV, et al. J Clin Oncol. 1994 Dec;12(12):2634-9. doi: 10.1200/JCO.1994.12.12.2634. J Clin Oncol. 1994. PMID: 7527455

3

Frequent abnormalities of TSG101 transcripts in human prostate cancer.

Sun Z, Pan J, Bubley G, Balk SP. Sun Z, et al. Oncogene. 1997 Dec 18;15(25):3121-5. doi: 10.1038/sj.onc.1201521. Oncogene. 1997. PMID: 9444960

4

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Signoretti S, et al. J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25. doi: 10.1093/jnci/92.23.1918. J Natl Cancer Inst. 2000. PMID: 11106683

5

Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor.

Masiello D, Cheng S, Bubley GJ, Lu ML, Balk SP. Masiello D, et al. Among authors: bubley gj. J Biol Chem. 2002 Jul 19;277(29):26321-6. doi: 10.1074/jbc.M203310200. Epub 2002 May 15. J Biol Chem. 2002. PMID: 12015321 Free article.

6

Biology of prostate-specific antigen.

Balk SP, Ko YJ, Bubley GJ. Balk SP, et al. Among authors: bubley gj. J Clin Oncol. 2003 Jan 15;21(2):383-91. doi: 10.1200/JCO.2003.02.083. J Clin Oncol. 2003. PMID: 12525533 Review.

7

Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.

Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M. Rossi S, et al. Mol Cancer Res. 2003 Aug;1(10):707-15. Mol Cancer Res. 2003. PMID: 12939396

8

Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients.

Spentzos D, Mantzoros C, Regan MM, Morrissey ME, Duggan S, Flickner-Garvey S, McCormick H, DeWolf W, Balk S, Bubley GJ. Spentzos D, et al. Among authors: bubley gj. Clin Cancer Res. 2003 Aug 15;9(9):3282-7. Clin Cancer Res. 2003. PMID: 12960113 Clinical Trial.

9

Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.

George DJ, Regan MM, Oh WK, Tay MH, Manola J, Decalo N, Duggan S, Dewolf WC, Kantoff PW, Bubley GJ. George DJ, et al. Among authors: bubley gj. Urology. 2004 Feb;63(2):327-32. doi: 10.1016/j.urology.2003.09.059. Urology. 2004. PMID: 14972483

10

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, DiPaola RS, Small EJ. Oh WK, et al. Among authors: bubley gj. J Clin Oncol. 2004 Sep 15;22(18):3705-12. doi: 10.1200/JCO.2004.10.195. Epub 2004 Aug 2. J Clin Oncol. 2004. PMID: 15289492 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters